Improved safety and efficacy of 213Bi-DOTATATE-targeted alpha therapy of somatostatin receptor-expressing neuroendocrine tumors in mice pre-treated with L-lysine.
about
Improved safety and efficacy of 213Bi-DOTATATE-targeted alpha therapy of somatostatin receptor-expressing neuroendocrine tumors in mice pre-treated with L-lysine.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Improved safety and efficacy o ...... ice pre-treated with L-lysine.
@en
Improved safety and efficacy o ...... ice pre-treated with L-lysine.
@nl
type
label
Improved safety and efficacy o ...... ice pre-treated with L-lysine.
@en
Improved safety and efficacy o ...... ice pre-treated with L-lysine.
@nl
prefLabel
Improved safety and efficacy o ...... ice pre-treated with L-lysine.
@en
Improved safety and efficacy o ...... ice pre-treated with L-lysine.
@nl
P2093
P2860
P1433
P1476
Improved safety and efficacy o ...... ice pre-treated with L-lysine.
@en
P2093
Erik de Blois
Ho Sze Chan
Jeffrey P Norenberg
Marion de Jong
Mark W Konijnenberg
Mehran Makvandi
Monique Nysus
Robert W Atcher
Tamara Daniels
Wouter A Breeman
P2860
P2888
P356
10.1186/S13550-016-0240-5
P577
2016-11-21T00:00:00Z
P6179
1038129972